Novogen Company Profile (NASDAQ:NVGN)

About Novogen

Novogen logoNovogen Limited (Novogen) is a drug discovery company. The Company is primarily engaged in pharmaceutical research and development. The Company's operations include CanTx Inc., its United States-based joint venture company with Yale University. Novogen has two drug technology platforms (the superbenzopyrans (SBPs) and anti-tropomyosins (ATMs)) yielding drug candidates that have application across a range of degenerative diseases. The Company's product candidates include Cantrixil, Anisina and Trilexium (TRXE-009). The Company's target indication for Cantrixil is ovarian cancer and Diffuse Intrinsic Pontine Glioma (DIPG) for Trilexium. The initial target pediatric indication for Anisina is neuroblastoma. The Company primarily focuses on four therapeutic areas: oncology, degenerative diseases, regenerative medicine and autoimmune diseases. It is engaged in pre-clinical steps to undergo a Phase I study for Cantrixil, Anisina and Trilexium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NVGN
  • CUSIP:
Key Metrics:
  • Previous Close: $2.04
  • 50 Day Moving Average: $1.908
  • 200 Day Moving Average: $2.076
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -101.80
  • P/E Growth: 0.000
  • Market Cap: $35.00M
  • Outstanding Shares: 17,189,000
  • Beta: 0.09
Additional Links:
Companies Related to Novogen:

Analyst Ratings

Consensus Ratings for Novogen (NASDAQ:NVGN) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Novogen (NASDAQ:NVGN)
Show:
DateFirmActionRatingPrice TargetDetails
7/31/2015HC WainwrightReiterated RatingBuy$8.50 -> $5.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Novogen (NASDAQ:NVGN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Novogen (NASDAQ:NVGN)
Current Year EPS Consensus Estimate: $-0.020 EPS
Next Year EPS Consensus Estimate: $-0.020 EPS

Dividends

Dividend History for Novogen (NASDAQ:NVGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novogen (NASDAQ:NVGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Novogen (NASDAQ:NVGN)
DateHeadline
publicnow.com logoNovogen Submits IND Application to the US FDA for Cantrixil in Ovarian Cancer (NASDAQ:NVGN)
www.publicnow.com - August 15 at 8:46 AM
nasdaq.com logoNovogen Submits IND Application For Cantrixil In Ovarian Cancer To FDA (NASDAQ:NVGN)
www.nasdaq.com - August 12 at 9:46 AM
finance.yahoo.com logoNovogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in Ovarian Cancer (NASDAQ:NVGN)
finance.yahoo.com - August 11 at 9:46 AM
4-traders.com logoNovogen : Graham Kelly seeks cash for new Australia oncology biotech (NASDAQ:NVGN)
www.4-traders.com - June 29 at 6:27 PM
finance.yahoo.com logoNovogen Patent Covering Anisina(TM) Has Proceeded to Grant (NASDAQ:NVGN)
finance.yahoo.com - June 13 at 8:30 PM
publicnow.com logoNovogen Patent Covering Anisina Has Proceeded to Grant (NASDAQ:NVGN)
www.publicnow.com - June 13 at 7:09 PM
News IconNovogen Limited Ads (NASDAQ:NVGN) Short Interest Decreased By 9.69% - Wall Street Hints and News (NASDAQ:NVGN)
hintsnewsnetwork.com - May 26 at 2:31 PM
publicnow.com logoEdison Investment Research Report maintains valuation as Novogen resumes 100% ownership of Cantrixil (NASDAQ:NVGN)
www.publicnow.com - May 9 at 9:38 PM
prnewswire.com logoNovogen Provides Update On Development Of Cantrixil - PR Newswire (press release) (NASDAQ:NVGN)
www.prnewswire.com - May 3 at 2:24 PM
News IconNovogen Limited Ads (NASDAQ:NVGN) Shorted Shares Decreased By 27% - B.O.D.Y Confidential (NASDAQ:NVGN)
www.bodyconfidential.com - May 3 at 2:24 PM
finance.yahoo.com logoNovogen Provides Update On Development Of Cantrixil (NASDAQ:NVGN)
finance.yahoo.com - May 1 at 10:43 PM
seekingalpha.com logoAnavex Life Sciences: Miracle Drug With A Toxic Financing Set For A Severe Decline In Price - Seeking Alpha (NASDAQ:NVGN)
seekingalpha.com - April 27 at 2:54 PM
News IconNovogen Limited Ads (NASDAQ:NVGN) Short Interest Increased By 41.32% - The Post (NASDAQ:NVGN)
www.bibeypost.com - April 23 at 2:22 PM
publicnow.com logoCantrixil (TRXE-002-1) Abstract (AACR Annual Meeting 2016) (NASDAQ:NVGN)
www.publicnow.com - April 17 at 8:36 PM
News IconWhat's Ahead for Novogen Limited (ADR) After Today's Huge Increase? - Stock Caller (NASDAQ:NVGN)
www.stockcaller.com - April 15 at 2:49 PM
investorplace.com logo6 Pharmaceuticals Stocks to Sell Now - Investorplace.com (NASDAQ:NVGN)
investorplace.com - April 8 at 2:29 PM
kcregister.com logoMorning Buzz: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Novogen Limited (NASDAQ:NVGN), Fleetmatics ... - KC Register (NASDAQ:NVGN)
www.kcregister.com - March 24 at 2:51 PM
News IconRecap for Traders: Continental Building Products (NYSE:CBPX), WPX Energy (NYSE:WPX), Novogen Limited (NASDAQ:NVGN), Charles & Colvard (NASDAQ:CTHR) (NASDAQ:NVGN)
www.gaininggreen.com - March 23 at 1:16 PM
News IconNovogen Limited (ADR) (NASDAQ:NVGN)'s Company Shares Increased 9.55% After Low Volatility - Stock Caller (NASDAQ:NVGN)
www.stockcaller.com - March 22 at 1:44 PM
clintongazette.com logoNovogen Limited Ads (NASDAQ:NVGN) Short Interest Decreased By 10.15% - Clinton Financial (NASDAQ:NVGN)
www.clintongazette.com - March 21 at 2:11 PM
streetinsider.com logoForm 6-K NOVOGEN LTD For: Mar 17 - StreetInsider.com (NASDAQ:NVGN)
www.streetinsider.com - March 17 at 1:42 PM
News IconNovogen Limited Ads (NASDAQ:NVGN) Shorted Shares Decreased By 10.15% - RiversideGazette.com (NASDAQ:NVGN)
www.riversidegazette.com - March 17 at 1:41 PM
benzinga.com logoNovogen Receives R&D Tax Incentive Cash Refund - Benzinga (NASDAQ:NVGN)
www.benzinga.com - March 17 at 1:41 PM
finance.yahoo.com logoNovogen Receives R&D Tax Incentive Cash Refund (NASDAQ:NVGN)
finance.yahoo.com - March 16 at 10:02 PM
twst.com logoNovogen Limited: Novogen Withdraws EGM Resolution to Increase Remuneration Cap - The Wall Street Transcript (NASDAQ:NVGN)
www.twst.com - March 11 at 1:01 PM
News IconWhat's Propelling Novogen Limited (ADR) to Increase So Much? - Business Standard Tribune (NASDAQ:NVGN)
www.standardtrib.com - March 9 at 1:02 PM
News IconAnalysts maintain 5.0 on Novogen Limited (NASDAQ:NVGN) - Hints News Network (NASDAQ:NVGN)
hintsnewsnetwork.com - March 4 at 12:41 PM
News IconAnalysts Release New Consensus Estimates for Novogen Limited (NASDAQ:NVGN) - Engelwood Daily (NASDAQ:NVGN)
www.engelwooddaily.com - March 1 at 12:39 PM
News IconNovogen Limited: Target Price of 5.0 expected - Hints News Network (NASDAQ:NVGN)
hintsnewsnetwork.com - February 26 at 12:33 PM
News IconNovogen Limited Ads (NASDAQ:NVGN) Shorts Decreased by 6.47% After Short Covering - Stock Caller (NASDAQ:NVGN)
www.stockcaller.com - February 26 at 12:33 PM
News IconCutting Edge Stocks in Focus: Novogen Limited (NASDAQ:NVGN), American Science & Engineering (NASDAQ:ASEI ... - Seneca Globe (NASDAQ:NVGN)
senecaglobe.com - February 23 at 11:56 AM
clintongazette.com logoWhat's Ahead for Novogen Limited (ADR) After Today's Huge Increase? - Clinton Financial (NASDAQ:NVGN)
www.clintongazette.com - February 20 at 12:20 PM
benzinga.com logoNovogen Patent Covering Cantrixil, Trilexium has been Granted in Australia - Benzinga (NASDAQ:NVGN)
www.benzinga.com - February 19 at 12:41 PM
feeds.benzinga.com logoNovogen Patent Covering Cantrixil, Trilexium has been Granted in Australia (NASDAQ:NVGN)
feeds.benzinga.com - February 19 at 5:16 AM
finance.yahoo.com logoNovogen Patent Covering Cantrixil And Trilexium Has Proceeded To Grant (NASDAQ:NVGN)
finance.yahoo.com - February 19 at 12:11 AM
News IconNovogen Limited Ads (NASDAQ:NVGN) Shorts Decreased by 6.47% After Short Covering - fdanewsalert.com (NASDAQ:NVGN)
www.fdanewsalert.com - February 17 at 12:32 PM
seekingalpha.com logoTapImmune Tackles Ovarian Cancer In Fast Track Phase II Clinical Trials - Seeking Alpha (NASDAQ:NVGN)
seekingalpha.com - February 9 at 11:49 AM
News IconFrigate Ventures Lp Sold More Novogen Ltd Shares - fdanewsalert.com (NASDAQ:NVGN)
www.fdanewsalert.com - February 6 at 11:44 AM
benzinga.com logoNovogen Names John O'Connor as Chairman - Benzinga (NASDAQ:NVGN)
www.benzinga.com - February 5 at 11:53 AM
feeds.benzinga.com logoNovogen Names John O'Connor as Chairman (NASDAQ:NVGN)
feeds.benzinga.com - February 5 at 5:39 AM
finance.yahoo.com logo3:28 am Novogen appoints John O'Connor as new Chairman (NASDAQ:NVGN)
finance.yahoo.com - February 5 at 3:28 AM
finance.yahoo.com logoNovogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed (NASDAQ:NVGN)
finance.yahoo.com - February 5 at 2:19 AM
publicnow.com logoLetter to Shareholders from CEO James Garner (NASDAQ:NVGN)
www.publicnow.com - January 31 at 4:39 PM
us.rd.yahoo.com logoNovogen leaps on cancer drug study news (NASDAQ:NVGN)
us.rd.yahoo.com - January 14 at 11:05 AM
finance.yahoo.com logoNovogen appoints new CEO (NASDAQ:NVGN)
au.finance.yahoo.com - December 9 at 7:56 PM
finance.yahoo.com logoNovogen Appoints Dr James Garner as Chief Executive Officer (NASDAQ:NVGN)
finance.yahoo.com - December 9 at 4:59 PM
finance.yahoo.com logoNOVOGEN LTD Financials (NASDAQ:NVGN)
finance.yahoo.com - December 8 at 1:16 PM
finance.yahoo.com logoNovogen Engages Contract Research Organisation to Conduct Cantrixil Phase 1 Clinical Trial (NASDAQ:NVGN)
finance.yahoo.com - November 23 at 7:38 PM
finance.yahoo.com logoNovogen Patent Covering Cantrixil and Trilexium Accepted in Australia (NASDAQ:NVGN)
finance.yahoo.com - November 11 at 7:04 PM
finance.yahoo.com logoPreclinical Studies Justify Mode of Delivery and Dosing Regimen for Anisina (NASDAQ:NVGN)
finance.yahoo.com - November 10 at 5:34 PM

Social

Novogen (NASDAQ:NVGN) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff